Skip to main content
. 2023 Sep 1;26(5):266–276. doi: 10.5223/pghn.2023.26.5.266

Table 3. HMO profiles by maternal factors.

HMO profiles (mg/L) Method of delivery* Body mass index (kg/m2) Number of children
Vaginal Caesarean <18.5 18.5–22.9 >23 1 2 >3
2’FL 2,017 (61–3,201) 2,437 (122–3,842) 1,934 (998–4,620) 2,094 (339–3,237) 2,150 (61–3,870) 2,409 (364–3,931) 1,666 (49–4,069) 2,150 (59–5,167)
LNFP I 432 (138–1,343) 560 (123–1,398) 135 (87–19,761) 598 (207–1,076) 317 (112–1,407) 467 (136–1,452) 500 (112–1,343) 389 (166–917)
LNT 109 (64–204) 106 (53–239) 41 (27–68) 123 (81–220) 103 (60–204) 115 (57–189) 122 (57–215) 103 (71–238)
LNnT 67 (38–114) 82 (33–116) 28 (20–33) 83 (49–118) 69 (36–109) 78 (37–111) 67 (36–118) 63 (39–126)
3’SL 188 (145–238) 184 (112–259) 128 (70–144) 183 (149–233) 195 (132–261) 188 (158–223) 181 (132–251) 209 (137–261)
6’SL 188 (144–233) 182 (112–256) 128 (70–144) 183 (148–232) 192 (132–249) 186 (154–217) 181 (132–250) 208 (136–260)

Values are presented as median (interquartile range).

HMO: human milk oligosaccharides, 2’FL: 2’-fucosyllactose, LNFP I: lacto-N-fucopentaose I, LNT: lacto-N-tetraose, LNnT: lacto-N-neotetraose, 3’SL: 3’-sialyllactose, 6’SL: 6’-sialyllactose.

*Mann-Whitney test.

Kruskal-Wallis test.